AMERICAN CENTURY COMPANIES INC
Position in ARQT — Arcutis Biotherapeutics, Inc.
CIK 748054
KANSAS CITY, MO
Position in ARQT
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$50,474,312
+$16,000,661 QoQ
Shares Held
1,925,031
+31.6% QoQ
Ownership
1.53%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#17
of 271 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 86%
Shared 14%
None 0%
Common Shares in ARQT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERICAN CENTURY COMPANIES INC holds $3,618,743,392 across 179 Biotechnology names. ARQT ranks #20 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,853,956 | $558,096,374 | |
| 2 | ASND |
Ascendis Pharma A/S
|
1,400,575 | $373,561,364 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
580,901 | $288,550,953 | |
| 4 | ARGX |
Argenx SE
|
173,193 | $160,683,269 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
1,947,076 | $154,383,656 | |
| 6 | EXEL |
Exelixis, Inc.
|
1,791,664 | $97,484,438 | |
| 7 | HRMY |
Harmony Biosciences Holdings, Inc.
|
2,539,512 | $92,463,631 | |
| 8 | GPCR |
Structure Therapeutics Inc.
|
1,682,179 | $90,282,546 |
All Filings in ARQT
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $50,474,312 | 1,925,031 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $34,473,651 | 1,463,228 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $42,606,791 | 1,467,176 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $31,337,559 | 1,662,470 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $24,174,784 | 1,724,307 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $25,844,974 | 1,652,492 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $22,722,978 | 1,631,226 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $13,618,092 | 1,464,311 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $11,454,810 | 1,231,700 | Shares | Defined | 2024-08-07 | |
| 2024-03-31 | $10,315,774 | 1,040,946 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $2,945,123 | 911,803 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $2,708,599 | 510,094 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,859,146 | 509,879 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $5,588,209 | 508,019 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $8,597,157 | 580,889 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $11,139,906 | 582,936 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $12,032,563 | 564,644 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $10,103,006 | 524,559 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $10,101,852 | 487,071 | Shares | Defined | 2022-02-07 | |
| 2021-09-30 | $8,984,407 | 376,074 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $10,277,959 | 376,620 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $10,871,778 | 375,796 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $8,109,879 | 288,300 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||